NDC 80432-056

Griseofulvin Oral Suspension

Griseofulvin Oral Suspension

Griseofulvin Oral Suspension is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Trirx Huntsville Pharmaceutical Services Llc. The primary component is Griseofulvin.

• Product ID: 80432-056_f1ea506d-0062-7849-e053-2995a90a94ea
• NDC: 80432-056
• Product Type: Human Prescription Drug
• Proprietary Name: Griseofulvin Oral Suspension
• Generic Name: Griseofulvin Oral Suspension
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2022-08-09
• Marketing Category: ANDA /
• Application Number: ANDA065438
• Labeler Name: TriRx Huntsville Pharmaceutical Services LLC
• Substance Name: GRISEOFULVIN
• Active Ingredient Strength: 125 mg/5mL
• Pharm Classes: Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2024-12-31

Packaging

NDC 80432-056-11

118 mL in 1 BOTTLE (80432-056-11)

• Marketing Start Date: 2022-08-09
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details